Recent trials have helped to clarify indications for the initial pharmacological therapy of
hypertension. Both the Joint National Committee on Prevention, Detection, Evaluation, and …

Pharmacological treatment of hypertension represents a cost‐effective way for preventing
cardiovascular and renal complications. To benefit maximally from antihypertensive …

Approximately 50 million Americans have hypertension. 8 As the population of the United
States increases in age, the burden of uncontrolled hypertension will continue to contribute …

Abstract The 2017 American College of Cardiology/American Heart Association
hypertension guidelines diagnose hypertension if systolic blood pressure (SBP) is≥ 130 …

Arterial hypertension is the most common chronic disease in developed countries and it is
the leading risk factor for stroke, ischemic heart disease, congestive heart failure, chronic …

The core issue dividing the World Health Organization-International Society of Hypertension
(WHO–ISH) guidelines from the American recommendations is the choice of first-line drugs …

Eur J Clin Invest 2012 Abstract Background About half of the global burden of
cardiovascular disease has been attributed to high blood pressure (BP). Worldwide, 7· 6 …

968 Circulation Research March 29, 2019 hypertension and lead to more precise therapies,
as well as reduced morbidity and mortality. Finally, Mancia et al12 review the evidence that …

Hypertension is a major cause of cardiovascular disease and deaths worldwide especially
in low-and middle-income countries. Despite the availability of safe, well-tolerated, and cost …

For most patients with systemic hypertension, long-term drug treatment is indicated and is
beneficial. There is overwhelming evidence to suggest that antihypertensive drugs offer …